 APVO | Aptevo Therapeutics Company profile
Company profileAptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patientsâ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology â the ADAPTIR⢠modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases.
Address2401 4th Avenue | NotesJump to (Finance sites)         ResearchInvestor pageaptevotherapeutics.gcs-web.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed. A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology |